Issue 4/2013
Content (28 Articles)
Recent advances in reconstructive surgery: head and neck reconstruction
Minoru Sakuraba, Shimpei Miyamoto, Yoshihiro Kimata, Takashi Nakatsuka, Kiyonori Harii, Satoshi Ebihara, Ryuichi Hayashi
Recent advances in reconstructive surgery for bone and soft tissue sarcomas
Masayuki Sawaizumi, Tomohiro Imai, Seiichi Matsumoto
Influence of a multidisciplinary cancer board on treatment decisions
Kenji Nemoto, Misako Murakami, Mayumi Ichikawa, Ibuki Ohta, Takuma Nomiya, Mayumi Yamakawa, Yuriko Itho, Tadahisa Fukui, Takashi Yoshioka
The contribution of neck dissection for residual neck disease after chemoradiotherapy in advanced oropharyngeal and hypopharyngeal squamous cell carcinoma patients
Masahiro Suzuki, Daisuke Kawakita, Nobuhiro Hanai, Hitoshi Hirakawa, Taijiro Ozawa, Akihiro Terada, Koichi Omori, Yasuhisa Hasegawa
The relationship between glucose metabolism disorders and malignant thyroid disease
Ayse Ocak Duran, Cüneyd Anil, Alptekin Gursoy, Aslı Nar, Ozden Altundag, Neslihan Bascil Tutuncu
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane
Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)
Kenjiro Aogi, Toshiaki Saeki, Seigo Nakamura, Masahiro Kashiwaba, Nobuaki Sato, Norikazu Masuda, Yoshiaki Rai, Shinji Ohno, Katsumasa Kuroi, Reiki Nishimura, Keiko Miyakoda, Futoshi Akiyama, Masafumi Kurosumi, Tadashi Ikeda
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?
Erion Dobi, Fernando Bazan, Armelle Dufresne, Martin Demarchi, Cristian Villanueva, Loic Chaigneau, Philipe Montcuquet, Arben Ivanaj, Jean Loup Sautière, Yolande Maisonnette-Escot, Laurent Cals, Marie Paule Algros, Anne-Sophie Woronoff, Xavier Pivot
The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan
Chin-Chan Lin, Hui-Wen Chang, Chen-Yuan Lin, Chang-Fang Chiu, Shin-Pen Yeh
A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients
Hiroji Iwata, Masaru Narabayashi, Yoshinori Ito, Shigehira Saji, Yasuhiro Fujiwara, Shigeyuki Usami, Koichi Katsura, Yasutsuna Sasaki
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas
Oscar Fernández-Guinea, Almudena Álvarez-Cofiño, Noemí Eiró, Luis O. González, José M. del Casar, Belen Fernandez-Garcia, Maria L. Lamelas, Alejandro Andicoechea, Francisco J. Vizoso
Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances
Guo-shun Shu, Fang Lv, Zhu-lin Yang, Xiong-ying Miao
Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma
Lkhagva-Ochir Tovuu, Satoru Imura, Tohru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Shuichi Iwahashi, Yu Saito, Shinichiro Yamada, Michihito Asanoma, Hidenori Miyake, Mitsuo Shimada
Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study
Ying Qiu, Mark M. Yun, Ming Bao Xu, Yi Zhong Wang, Sheng Yun
Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population
Song Wang, Yang Li, Xiang-Dong Liu, Chun-Xiong Zhao, Kun-Qing Yang
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer
Hiroshi Soeda, Hideki Shimodaira, Mika Watanabe, Takao Suzuki, Makio Gamoh, Takahiro Mori, Keigo Komine, Noriyuki Iwama, Shunsuke Kato, Chikashi Ishioka
Feasibility study of S-1 adjuvant chemotherapy in patients with colorectal cancer
Masaichi Ogawa, Michiaki Watanabe, Tetsuya Kobayashi, Ken Eto, Akihiro Oda, Tadashi Anan, Takenori Hayashi, Yoshinobu Mitsuyama, Katsuhiko Yanaga
Cetuximab-induced skin reactions are suppressed by cigarette smoking in patients with advanced colorectal cancer
Makoto Kajizono, Madoka Saito, Megumu Maeda, Kazuhiko Yamaji, Satoko Fujiwara, Yoichi Kawasaki, Hisashi Matsunaga, Toshiaki Sendo
Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients
Seiya Saito, Naoko Hayashi, Nobutaka Sato, Masaaki Iwatsuki, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto, Masayuki Watanabe, Minoru Yoshida, Kenji Sakai, Takashi Katsumori, Shigeru Katahuchi, Nobuyuki Shigaki, Kazutaka Yamada, Masami Kimura, Tomio Tanigawa, Sadamu Takano, Masafumi Kuramoto, Hideo Baba
Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?
Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara
Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer
Koji Hatano, Kazuo Nishimura, Yasutomo Nakai, Takahiro Yoshida, Mototaka Sato, Atsunari Kawashima, Masatoshi Mukai, Akira Nagahara, Motohide Uemura, Daizo Oka, Masashi Nakayama, Hitoshi Takayama, Kiyonori Shimizu, Norio Meguro, Tsuyoshi Tanigawa, Seiji Yamaguchi, Akira Tsujimura, Norio Nonomura
Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
Takeshi Yamada, Masashi Nakayama, Tomohito Shimizu, Shinpei Nonen, Yasutomo Nakai, Kazuo Nishimura, Yasushi Fujio, Akihiko Okuyama, Junichi Azuma, Norio Nonomura
Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients
Yuki Kita, Yosuke Shimizu, Takahiro Inoue, Tomomi Kamba, Koji Yoshimura, Osamu Ogawa
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study
Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura
Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience
Naotaka Fukui, Yusuke Kohno, Jun-Ichiro Ishioka, Hiroshi Fukuda, Yukio Kageyama, Yotsuo Higashi
Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer
Tetsuya Sasaki, Ken-ichi Fujita, Yu Sunakawa, Hiroo Ishida, Keishi Yamashita, Keisuke Miwa, Shigehira Saji, Yasuhisa Kato, Yasutsuna Sasaki
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan
Yuka Horiuchi-Yamamoto, Akihiko Gemma, Hiroyuki Taniguchi, Yoshikazu Inoue, Fumikazu Sakai, Takeshi Johkoh, Kiminori Fujimoto, Shoji Kudoh